Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |